The global digital mammography market is poised for remarkable growth in the coming years, fueled by a combination of factors that underscore its critical role in early breast cancer detection. This non-invasive, safe, and effective screening technology has proven to deliver superior results, eliminating the need for re-tests and follow-up screenings. With breast cancer cases on the rise, the demand for diagnostic devices is expected to skyrocket.
Rising Prevalence of Breast Cancer
In 2022, the United States alone is estimated to have seen 287,850 new cases of invasive breast cancer and 51,400 new non-invasive cases, affecting one in every eight American women. The urgency for digital mammography systems is clear, as early detection remains paramount in breast cancer treatment.
Government Initiatives and Collaborations
Government initiatives worldwide, such as the PINK Project in Punjab, have reinforced the importance of breast cancer screening. Collaborations like the one between Roche Pharma India, Niramai Health, and RadNet, or Candelis Inc. and GE Healthcare, are further driving the markets expansion. These partnerships not only promote research and development but also upgrade existing technology to meet the ever-evolving demands of patients.
The Role of AI
Artificial intelligence is revolutionizing digital mammography and digital breast tomosynthesis, contributing to various aspects of breast cancer care, from image enhancement and denoising to risk prediction, diagnosis, therapy selection, and outcome prediction. Recent funding for AI-powered breast cancer screening software, like Varas EUR 6.5 million Series A, highlights the immense potential for innovation in this field.
Cost-Effective 2D Full-Field Digital Mammography Tomosynthesis
The 2D full-field digital mammography tomosynthesis segment is projected to dominate the market due to its cost-effectiveness, reduced radiation exposure, and acceptance as the gold standard for breast cancer diagnosis. Lower recall rates and widespread insurance coverage further bolster the adoption of this technology.
North America Leads the Way
North America leads the global digital mammography market, driven by the adoption of advanced mammography units, expanding government reimbursements, and a focus on breast cancer research and imaging breakthroughs. The rising burden of breast cancer and healthcare expenses prompt healthcare facilities to invest in cutting-edge technology.
Asia Pacifics Promising Growth
Asia Pacific is expected to experience significant growth, driven by increasing breast cancer prevalence and heightened awareness of mammographys benefits. Government initiatives for free cancer screening programs, such as those in Goa and Chennai, are boosting demand for mammography systems in the region.
Competitive Landscape
Key players in the digital mammography market include Hologic Inc., GE Healthcare, Koninklijke Philips NV, Siemens Healthcare GmBH, Fujifilm Corporation, PLANMED OY, Toshiba Medical Systems, and Metaltronica S.p.A. Innovative solutions from companies like Volpara Health and ScreenPoint Medical, with their AI-driven breast care systems, are further enriching the markets offerings.
As the global fight against breast cancer intensifies, the digital mammography market stands at the forefront, providing cutting-edge solutions to improve early detection, diagnosis, and treatment, ultimately saving lives.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/digital-mammography-market
Our Blogs:
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of
services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
This press release first seen on Brilad
COMTEX_442040367/2840/2023-10-17T19:35:40
Julian Lopez is professor emeritus of finance, served as the founding academic affairs dean and founding chair of the finance department.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No journalist was involved in the writing and production of this article.